We are live on ! Find out more
Canada Life

Canada Life Portfolio holdings

AUM $55.8B
1-Year Est. Return 26.04%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+26.04%
3 Year Est. Return
+87.85%
5 Year Est. Return
+117.08%
10 Year Est. Return
+382.61%
AUM
$46B
AUM Growth
+$3.76B
Cap. Flow
+$1.31B
Cap. Flow %
2.85%
Top 10 Hldgs %
15.96%
Holding
2,794
New
1,683
Increased
565
Reduced
451
Closed
36

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$82M
2
MFC icon
Manulife Financial
MFC
+$61.4M
3
BMY icon
Bristol-Myers Squibb
BMY
+$50.1M
4
V icon
Visa
V
+$49.7M
5
CL icon
Colgate-Palmolive
CL
+$48.5M

Sector Composition

Rank Sector Weight
1 Financials 21%
2 Technology 16.36%
3 Healthcare 10.14%
4 Consumer Discretionary 9.18%
5 Communication Services 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NWLI
2301
DELISTED
National Western Life Group, Inc. Class A
NWLI
$45K ﹤0.01%
+159
New +$42.6K
VCRA
2302
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$45K ﹤0.01%
+2,209
New +$48.5K
FLXN
2303
DELISTED
Flexion Therapeutics, Inc.
FLXN
$45K ﹤0.01%
+2,180
New +$36.8K
ADVM
2304
DELISTED
Adverum Biotechnologies
ADVM
$44K ﹤0.01%
+387
New +$34.1K
CERS icon
2305
Cerus
CERS
$474M
$44K ﹤0.01%
+10,518
New +$45.3K
EQBK icon
2306
Equity Bancshares
EQBK
$1.05B
$44K ﹤0.01%
+1,442
New +$41.2K
FRPH icon
2307
FRP Holdings
FRPH
$421M
$44K ﹤0.01%
+1,774
New +$44.6K
PACB icon
2308
Pacific Biosciences
PACB
$370M
$44K ﹤0.01%
8,661
RVNC
2309
DELISTED
Revance Therapeutics, Inc.
RVNC
$44K ﹤0.01%
+2,750
New +$42.6K
MNRL
2310
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$44K ﹤0.01%
+2,064
New +$40.2K
TEN
2311
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$44K ﹤0.01%
+3,419
New +$44.8K
NIC icon
2312
Nicolet Bankshares
NIC
$3.62B
$43K ﹤0.01%
+584
New +$41.2K
OBK icon
2313
Origin Bancorp
OBK
$1.66B
$43K ﹤0.01%
+1,146
New +$40.2K
TBBK icon
2314
The Bancorp
TBBK
$2.84B
$43K ﹤0.01%
+3,372
New +$37.8K
TCRT icon
2315
Alaunos Therapeutics
TCRT
$4.86M
$43K ﹤0.01%
+61
New +$42K
AGEN
2316
Agenus
AGEN
$290M
$42K ﹤0.01%
527
+289
+121% +$19.4K
ALLO icon
2317
Allogene Therapeutics
ALLO
$694M
$42K ﹤0.01%
+1,627
New +$44.8K
AMC icon
2318
AMC Entertainment Holdings
AMC
$2.31B
$42K ﹤0.01%
+592
New +$52.1K
EVH icon
2319
Evolent Health
EVH
$447M
$42K ﹤0.01%
4,645
IBCP icon
2320
Independent Bank Corp
IBCP
$844M
$42K ﹤0.01%
+1,877
New +$41.5K
NVEC icon
2321
NVE Corp
NVEC
$609M
$42K ﹤0.01%
+596
New +$38.9K
RUSHB icon
2322
Rush Enterprises Class B
RUSHB
$6.14B
$42K ﹤0.01%
+2,068
New +$40.1K
VCEL icon
2323
Vericel Corp
VCEL
$2.31B
$42K ﹤0.01%
+2,462
New +$41.9K
WINA icon
2324
Winmark
WINA
$1.32B
$42K ﹤0.01%
+212
New +$38.2K
IMGN
2325
DELISTED
Immunogen Inc
IMGN
$42K ﹤0.01%
+8,366
New +$28.4K

Similar funds

Canada Life's Q4 2019 Portfolio in Review

As of Q4 2019, Canada Life held 2,794 positions worth $46B, up 8.9% from $42.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Canada Life's Q4 2019 filing shows 1,683 new, 565 increased, 451 reduced and 36 closed positions. Its largest new stake was Berkshire Hathaway Class A: 88 shares worth $29.7M. The largest sale was Apple, an estimated $167M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Technology and Healthcare.

  • Canada Life's largest Q4 2019 buy was Berkshire Hathaway Class A: 88 shares worth $29.7M.
  • Canada Life added most to Alibaba in Q4 2019, an estimated $82M increase.
  • Canada Life's biggest Q4 2019 reduction was Apple, cutting an estimated $167M.
  • Canada Life fully exited Celgene Corp in Q4 2019, selling an estimated $71.4M.
  • Canada Life's ten largest holdings make up 16% of its $46B portfolio in Q4 2019.
  • Canada Life opened 1,683 new positions and closed 36 in Q4 2019.
  • Canada Life's portfolio value rose 8.9% quarter-over-quarter to $46B.

Based on Canada Life's 13F filing for Q4 2019, filed 11 Feb 2020.